The Barbara Ann Karmanos Cancer Institute is pleased to announce the election of Shari Ferber Kaufman to its board of directors. Kaufman will serve a three-year term.
In her role, Kaufman will collaborate with other board members to support the Institute’s mission of leading transformative cancer care, research and education. Karmanos treats more than 12,000 new patients annually and is Michigan’s largest cancer care and research network.
“I am extremely pleased to welcome Shari to the board,” said Gerold Bepler, M.D., Ph.D., president and CEO of Karmanos Cancer Institute. “She joins a diverse and talented group of leaders and her perspective will be invaluable to Karmanos.”
Shari Ferber Kaufman is a graduate of the University of Michigan and the University of Detroit Mercy School of Law. She is a criminal defense attorney by profession and is engaged in many charitable and philanthropic organizations. Kaufman and her husband are the owners of HoMedics, Inc., a Michigan-based company leading in the global manufacturer of health and wellness products. Having dealt with cancer in her family and experiencing the devastating effects it can have on a loved one and their community, Kaufman brings a personal passion to the Karmanos board.
Her board service includes Hillel Day School, Frankel Jewish Academy, the National Board of Friends of the IDF, Holocaust Memorial Center, The Friendship Circle, American Red Magen David for Israel, Jewish Resource Center, Jewish Theological Seminary, Defeat the Label, Beth Ahm Synagogue, Jewish Federation of Detroit, B’nai B’rith Youth Organization and the National Board of Camp Ramah of Canada.
2020 Karmanos Cancer Institute Board of Directors
Timothy Monahan, Chair
Jim Bennethum (Ex Officio)
Gerold Bepler, M.D., Ph.D. (Ex Officio)
Armando R. Cavazos
Karen Cullen
Jeffery Davidson
David W. Drews
David E. Duprey
Thomas A. Goss
Shari Ferber Kaufman
Phil Incarnati (Ex Officio)
Tom Kalas (Ex Officio)
Maureen L. Stapleton
M. Roy Wilson, M.D. (Ex Officio)